1. Home
  2. Tech News
  3. Michael J. Fox Foundation, Intel explore technology to curb Parkinson’s disease

Michael J. Fox Foundation, Intel explore technology to curb Parkinson’s disease

Michael J. Fox Foundation, Intel explore technology to curb Parkinson’s disease

The Michael J. Fox Foundation for Parkinson’s Research (MJFF), the world largest non-profit funder of Parkinson’s research and Intel Corporation, a world leader in computer innovation have announced a collaboration aimed at improving research and treatment for Parkinson’s disease.

Medical experts consider Parkinson’s disease, a neurodegenerative brain disease second only to Alzheimer’s in worldwide prevalence.

According to Intel, the collaboration includes a multiphase research study using a new big data analytics platform that detects pattern in participant data collected from wearable technologies used to monitor symptoms.

This effort is an important step in enabling researchers and physicians to measure progression of the disease and to speed progress toward breakthroughs in drug development, according to the technology company.

“Nearly 200 years after Parkinson’s disease was first described by Dr. James Parkinson in 1817, we are still subjectively measuring Parkinson’s disease largely the same way doctors did then,” said Todd Sherer, CEO of The Michael J. Fox Foundation. “Data science and wearable computing hold the potential to transform our ability to capture and objectively measure patients’ actual experience of disease, with unprecedented implications for Parkinson’s drug development, diagnosis and treatment.”

“The variability in Parkinson’s symptoms creates unique challenges in monitoring progression of the disease,” said Diane Bryant, senior vice president and general manager of Intel’s Data Center Group. “Emerging technologies can not only create a new paradigm for measurement of Parkinson’s, but as more data is made available to the medical community, it may also point to currently unidentified features of the disease that could lead to new areas of research.”

MJFF and Intel initiated a study earlier this year to evaluate the usability and accuracy of wearable devices for tracking agreed physiological features from participants and using a big data analytics platform to collect and analyze the data.

Intel data scientists are now correlating the data collected to clinical observations and patient diaries to gauge the devices’ accuracy, and are developing algorithms to measure symptoms and disease progression.

Later this year, Intel and MJFF plan to launch a new mobile application that enables patients to report their medication intake as well as how they are feeling. The effort is part of the next phase of the study to enable medical researchers to study the effects of medication on motor symptoms via changes detected in sensor data from wearable devices, according to Intel.

[cactus-ads id="104721"]
Kayode Oladeinde Technology Journalist at Technology Times. Mobile: +234 (0) 7031526929